Takeda Cambridge

About:

Takeda Cambridge specializes in developing oral diabetes medications.

Website: http://www.takedacam.com/

Top Investors: Excalibur Fund Managers, Avlar BioVentures

Description:

Takeda Cambridge Limited (TCB) and its subsidiary TSP, have established world-class target identification and validation capabilities. Together they have developed a promising pipeline of novel drug discovery targets and compounds in key areas of unmet medical need such as CNS disorders, chronic pain and urology indications, endocrinology and metabolic-related diseases.